Cordis – A Cardinal Health Company
Gold Sponsors
http://www.cardinalhealth.com/cordisTogether, Cordis and Cardinal Health create an unmatched offering in the cardiovascular and broader medical device space. Already a leader in interventional cardiovascular technology, Cordis has combined with Cardinal Health to now offer high quality, daily-use products; reliable, trackable inventory and logistics; and deep analytic capabilities for a more comprehensive offering. Together, the companies bring unrivaled strengths to a global scale. Cordis will be the international engine for the combined venture with operations in countries around the world including Australia and New Zealand. This partnership uniquely positions Cardinal Health and Cordis to meet the evolving needs of more customers around the world. At a time of rapid evolution within healthcare, this makes the companies essential to care. In addition to this Cordis, Cardinal Health has recently entered into a distribution agreement with Biosensors that enables Cordis, Cardinal Health to sell Biosensors coronary stent portfolio in select countries in Europe, the Middle East, Africa (EMEA), as well as exclusive distribution in Australia and New Zealand. This announcement marks Cordis’ return to the drug eluting stent (DES) market and the first of a number of investments.